2027 Global Dietary Supplement Trends: Ingredients, Formats, And Regulations

The global dietary supplement industry stands at an inflection point. As consumer awareness deepens and scientific research advances, the market is undergoing a structural transformation that goes far beyond simple vitamin-and-mineral offerings. According to industry forecasts, the defining characteristic of 2027 will be functional specificity paired with experiential delivery-consumers no longer ask only what a supplement contains, but how it integrates into their daily lives, how it tastes, and how quickly they feel its effects.

This article examines 10 pivotal categories reshaping the supplement industry in 2027, analyzing featured ingredients, market conditions, target users, application scenarios, regulatory environment, and formulation implications. The table below offers an at-a-glance summary of the 10 categories and their featured ingredients.

 

No.	Popular Supplement Categories in 2027	Featured Ingredients
1	Sleep Support	Tomato Extract, Magnesium Glycinate, L-theanine, Ashwagandha, Magnesium L-Threonate, Probiotics, and Dietary Fiber
2	Gut Health	Probiotics, Prebiotics, Postbiotics, Digestive Enzymes, and Bacteriophages
3	Dietary Fiber	Gum Arabic, Arabinogalactan, β-Glucan, and Resistant Starch
4	Women's Health	Siberian Rhubarb, Asparagus, Chasteberry, Maca, Magnesium, Probiotics, Black Cohosh, Cranberry, and D-Mannose
5	Longevity and Healthy Aging	Spermidine, NMN, Resveratrol, Coenzyme Q10, and Fisetin
6	Nootropics and Cognitive Support	Creatine, Magnesium L-Threonate, Citicoline, Hericium Erinaceus, and Bacopa Monnieri
7	Sports Nutrition	Creatine, Protein, Electrolytes, β-Alanine, and Adaptogens (such as Rhodiola Rosea)
8	Men's Health	Ashwagandha, Zinc, Magnesium, Creatine, and Vitamin D
9	Children's Nutrition	Vitamin D, Omega-3, Magnesium, Probiotics, Choline, and Iron
10	Immune Support	Vitamin D, Zinc, Vitamin C, β-Glucan, and Mushroom Extracts (Reishi, Shiitake, and Turkey Tail Mushrooms)

 

 

A. Featured Ingredients: Tomato-derived phytomelatonin, magnesium glycinate, magnesium L-threonate, L-theanine, and ashwagandha.

B. Market Condition: The sleep supplement category is experiencing significant premiumization as single-ingredient melatonin products lose differentiation. Consumers increasingly understand that sleep quality involves stress modulation, emotional balance, and even gut health-not merely initiating drowsiness. This has driven formulators toward multi-ingredient systems that address the full sleep architecture rather than just sleep onset.

C. Target Users: Shift workers, frequent travelers managing jet lag, students during examination periods, and the growing population of adults reporting occasional sleep disturbances linked to digital device usage and irregular schedules.

D. Formulation and Delivery: Stick packs, ready-to-mix powders, and gummies have gained substantial traction in this category. Functional beverages designed for evening consumption represent an emerging format, offering the dual benefit of hydration and sleep support. Gummies and chewables remain popular for travelers seeking convenience without water.

E. Regulatory Environment: In the United States, melatonin is regulated as a dietary ingredient, though the FDA has not approved its use in children. Tomato-derived melatonin has achieved self-affirmed GRAS status for use in conventional foods and beverages. In the European Union, melatonin health claims are restricted; authorized claims relate to the reduction of time to fall asleep and the alleviation of jet lag, each subject to specific dosage conditions. Magnesium claims are permitted under Article 13.1 for "normal muscle function" and "reduction of tiredness," though sleep-specific claims generally require careful substantiation.

F. Formulation Consideration: The shift toward multi-ingredient sleep formulations requires careful attention to ingredient compatibility and sensory experience. Magnesium salts, particularly glycinate and L-threonate, can introduce bitterness or chalkiness that must be masked in powder and gummy formats. Tomato-derived melatonin offers a plant-based positioning that appeals to clean-label consumers but requires robust supply-chain documentation.

 

A. Featured Ingredients: Postbiotics (inactivated probiotics and their metabolites), probiotics, prebiotics, digestive enzymes, and bacteriophages

B. Market Condition: The gut health category has undergone a conceptual expansion from "digestive support" to "whole-body microecology." Scientific understanding of the gut-brain axis, immune regulation, and metabolic signaling has elevated gut health from a digestive concern to a systemic wellness priority. Postbiotics, in particular, have emerged as one of the fastest-growing ingredient classes in this category.

C. Target Users: Individuals with occasional digestive discomfort, those managing stress-related gut symptoms, immune-compromised consumers, and a growing base of "gut-curious" consumers who recognize the microbiome's role in overall health.

D. Formulation and Delivery: Capsules remain dominant for probiotic and postbiotic delivery due to stability considerations. However, powders designed for mixing into cold beverages are gaining traction, particularly for fiber-based products. Gummies, by contrast, present formulation challenges for live probiotics but work well for postbiotics and certain prebiotic fibers.

E. Regulatory Environment: The term "probiotic" itself is treated as a health claim under EU Regulation 1924/2006, severely limiting its use on product labels; no probiotic health claims have been authorized in the EU. Postbiotics, as inactivated microbial preparations, present a different regulatory profile. In the United States, the FDA requires New Dietary Ingredient (NDI) notification for ingredients not marketed before October 15, 1994, a requirement that affects many novel probiotic strains and postbiotic preparations.

F. Formulation Considerations: Stability and viability are central concerns for live probiotics, influencing both dosage form and packaging. Postbiotics offer significant advantages in shelf stability and formulation flexibility, enabling use in ambient-stable powders, gummies, and functional foods. The 2021 ISAPP definition of postbiotics-"preparations of inanimate microorganisms and/or their components that confer a health benefit to the host"-provides a scientific framework that can support responsible claims.

 

A. Featured Ingredients: Gum arabic, arabinogalactan, beta-glucan, and resistant starch

B. Market Condition: Dietary fiber is undergoing a reputational repositioning from a single-function ingredient ("regularity") to a multi-benefit component supporting cardiovascular health, immune function, and even cognitive well-being through the gut-brain axis. This shift has attracted consumers who previously associated fiber supplements with unpleasant gastrointestinal experiences.

C. Target Users: Health-conscious consumers seeking digestive comfort without bloating, individuals managing cholesterol levels, and those pursuing microbiome diversity as part of a broader wellness approach.

D. Formulation and Delivery: Gum arabic's high solubility and low viscosity make it particularly well-suited to powder formats that dissolve clear in water or juice. This transparency aligns with consumer expectations for a pleasant drinking experience. Fiber-enriched functional beverages represent a significant growth opportunity.

E. Regulatory Environment: In the United States, the FDA has established a definition of "dietary fiber" that includes certain isolated or synthetic fibers that demonstrate physiological benefits. In the EU, fiber claims are regulated under Regulation 1924/2006, with authorized claims for specific fiber sources such as barley grain fibre, oat grain fibre, and sugar beet fibre contributing to an increase in fecal bulk. Acacia gum (gum arabic) is generally recognized as safe (GRAS) and has a long history of use in food applications.

F. Formulation Considerations: The choice of fiber source significantly impacts the sensory profile of the finished product. Gum arabic's slow fermentation profile, compared to inulin or fructooligosaccharides, reduces the likelihood of gas and bloating, a key consumer complaint with traditional prebiotic fibers. This makes it an attractive option for products targeting sensitive populations or those seeking daily use without discomfort.

 

A. Featured Ingredients: Siberian rhubarb (Rheum rhaponticum), asparagus extract, chasteberry, maca, cranberry, and D-mannose

B. Market Condition: The women's health supplement category is expanding from a narrow focus on menopause management to encompass reproductive health, hormonal balance across the lifespan, healthy aging, and urinary tract support. Personalized nutrition trends are driving demand for products tailored to specific life stages rather than generic "women's formulas."

C. Target Users: Women in reproductive years managing cycle-related concerns, perimenopausal and menopausal women seeking non-hormonal support for symptom relief, and aging women focused on bone, cardiovascular, and cognitive health.

D. Formulation and Delivery: Capsules and tablets remain standard for standardized botanical extracts. However, gummies and powders are gaining ground for lifestyle-friendly positioning, particularly among younger women.

E. Regulatory Environment: Siberian rhubarb root extract has a distinctive regulatory history in Europe, where it has been used as a non-hormonal prescription medication for menopausal symptoms in certain European markets. Botanical claims in the EU remain legally uncertain. Following the CJEU's April 2025 judgment in Novel Nutriology (C-386/23), botanical health claims are prohibited in food supplement advertising unless covered by the transitional regime under Article 28(5) or (6) of Regulation 1924/2006-i.e., submitted for assessment before 19 January 2008. The Commission has not resumed its assessment of botanical claims. In the United States, botanical ingredients with a pre-1994 history of use in supplements are generally exempt from NDI notification, though novel extracts require careful review.

F. Formulation Considerations: The pharmaceutical heritage of Siberian rhubarb extract provides a strong scientific foundation for communication, but brands must navigate the boundary between structure/function claims and drug claims carefully. Standardization of botanical extracts is critical for consistency and regulatory defensibility.

 

A. Featured Ingredients: Spermidine, nicotinamide mononucleotide (NMN), resveratrol, water soluble coenzyme Q10, and fisetin

B. Market Condition: The longevity category has moved decisively from niche biohacker interest to mainstream consumer awareness. The focus has shifted from simply extending lifespan to extending healthspan-the period of life lived in good health. Cellular health mechanisms including autophagy, mitochondrial function, and NAD+ decline have become consumer-facing concepts.

C. Target Users: Adults aged 40-70 who are proactively managing aging, though younger "preventative" users are increasingly entering the category. The users include individuals with a strong interest in biohacking, those with a family history of age-related conditions, and health-conscious consumers who view supplementation as part of a comprehensive longevity strategy.

D. Formulation and Delivery: Powders are particularly well-suited to longevity formulations, which often combine multiple active ingredients at meaningful doses. Stick packs offer convenience and allow for higher ingredient loads than capsules. The "morning stack" concept-a daily powder or capsule regimen-has become a common consumer behavior.

E. Regulatory Environment: NAD+ precursors such as NMN and NR present complex regulatory considerations. In the United States, NMN's regulatory status has undergone significant reversals. In late 2022, the FDA determined that NMN was excluded from the dietary supplement definition due to prior drug investigation. However, following a citizen petition and litigation by the Natural Products Association, the FDA reversed this position in September 2025, confirming that NMN is not excluded from the dietary supplement definition and may be lawfully marketed as a supplement. The FDA issued confirmation letters to NMN suppliers in December 2025. Brands should still monitor ongoing legislative efforts to clarify DSHEA's drug preclusion clause, which remains a source of uncertainty for next-generation ingredients. Spermidine, as a naturally occurring polyamine found in food, has a clearer regulatory pathway than many novel ingredients. However, standardized wheat germ extracts require appropriate documentation, and no health claims for spermidine have been authorized in the EU.

F. Formulation Considerations: The stability and bioavailability of these ingredients vary considerably. NMN is highly hygroscopic and sensitive to moisture, requiring careful handling in powder processing to prevent crystallization and degradation. Spermidine-rich wheat germ extract offers a whole-food-derived positioning that resonates with clean-label consumers. Multi-ingredient longevity formulas require attention to potential interactions and cumulative effects.

 

A. Featured Ingredients: Magnesium L-threonate, creatine, citicoline, lion's mane mushroom, and bacopa monnieri

B. Market Condition: The cognitive support category has undergone a user transformation. No longer confined to senior memory support, nootropic supplements now target students, knowledge workers, and anyone seeking a competitive cognitive edge. The "brain nutrition" conversation has gained significant social media traction, driving awareness and trial.

C. Target Users: University students, professionals in high-cognitive-demand roles, gamers, and adults seeking to maintain cognitive function as they age. The audience is younger and more performance-oriented than the traditional memory supplement consumer.

D. Formulation and Delivery: Capsules remain dominant due to the stability requirements of many nootropic ingredients. However, powdered drink mixes positioned as "focus fuel" are gaining popularity. Gummies work well for lion's mane and certain mushroom extracts.

E. Regulatory Environment: The EU regulatory environment for cognitive health claims is particularly restrictive. Authorized claims are limited to minerals such as iodine, zinc, and iron for "normal cognitive function," and only for specific populations and wording. Claims related to "enhancement" or "optimization" are not permitted. In the United States, structure/function claims for cognitive support are permitted with appropriate disclaimers, though the FTC scrutinizes such claims for substantiation and potential deception.

F. Formulation Implications: Magnesium L-threonate's ability to cross the blood-brain barrier distinguishes it from other magnesium forms, but it is a proprietary ingredient requiring licensing considerations. Lion's mane mushroom extracts vary significantly in quality and standardization; beta-glucan content is a key marker for immune-active mushroom products.

 

 

A. Featured Ingredients: Creatine, protein, electrolytes, β-alanine, and adaptogens (such as Rhodiola Rosea)

B. Market Condition: The sports nutrition category has broadened dramatically. The audience now includes not just competitive athletes but recreational gym-goers, weekend warriors, active older adults, and "lifestyle athletes" who prioritize physical performance as part of a comprehensive wellness approach.

C. Target Users: Ages 18-70, with particular growth among women in strength training, older adults focused on muscle preservation, and individuals participating in recreational endurance activities.

D. Formulation and Delivery: Powders remain the dominant format for sports nutrition, allowing for high doses of creatine and protein. Ready-to-drink formats are gaining share, particularly for electrolyte and recovery beverages. Stick packs offer portability for travel and gym-bag convenience.

E. Regulatory Environment: Sports nutrition ingredients are generally well-established with a pre-1994 history of use as dietary ingredients in the U.S., simplifying NDI requirements. However, claims must adhere to structure/function standards in the US and the restrictive Article 13.1 framework in the EU. The FDA has issued warnings regarding certain sports supplement ingredients, and third-party certification programs (Informed Sport, NSF Certified for Sport) have become important trust signals.

F. Formulation Considerations: Creatine's extensive research base and established safety profile make it a foundational ingredient, but its gritty texture and low solubility create formulation challenges. Micronized and instantized forms improve mixability. Beta-alanine's paresthesia (tingling) effect is a known sensory characteristic that requires consumer education.

 

A. Featured Ingredients: Ashwagandha, zinc, magnesium, creatine, and vitamin D

B. Market Condition: The men's health supplement category is evolving from a testosterone-centric focus to a broader "men's vitality" positioning that encompasses energy, metabolic health, cognitive function, and stress management. Consumers increasingly seek multi-target products with clinical support rather than single-ingredient "boosters."

C. Target Users: Men aged 25-65, with younger men drawn to performance and vitality positioning, and older men focused on healthy aging, metabolic support, and maintaining physical function.

D. Formulation and Delivery: Capsules are standard for adaptogen and mineral combinations. Powders offer an opportunity for multi-ingredient formulations with higher doses. The "men's daily stack" concept is gaining traction.

E. Regulatory Environment: Ashwagandha has received significant regulatory attention. In the EU, the plant itself is not classified as a novel food, but high-concentration standardized extracts may require novel food assessment. The NIH has noted clinical evidence for stress and cortisol reduction, but claims must be framed within permitted structure/function language. Zinc has an authorized EU claim for maintenance of normal serum testosterone concentrations, and magnesium for normal muscle function.

F. Formulation Considerations: Ashwagandha root extract standardization is critical; withanolide content is a key marker. The combination of ashwagandha with magnesium and zinc creates a formulation that addresses both stress pathways and micronutrient sufficiency.

 

A. Featured Ingredients: Choline, vitamin D, omega-3 (DHA), magnesium, probiotics, and iron

B. Market Condition: Parents are increasingly discerning about children's supplements, seeking clean-label formulations with transparent sourcing, evidence-based dosing, and formats that children will actually consume. The category is moving away from sugar-laden gummies toward more functional formats.

C. Target Users: Parents of children aged 2-18, with particular concern for picky eaters, children with dietary restrictions, and those seeking to fill nutritional gaps identified by pediatric guidance.

D. Formulation and Delivery: Gummies remain the most popular format due to child acceptance, but clean-label gummies with minimal added sugar and natural colors are increasingly in demand. Chewable tablets offer a no-sugar option. Powders that can be mixed into milk or smoothies provide flexibility for younger children. Liquid formats address pill-swallowing difficulties.

E. Regulatory Environment: The infant formula "new national standard" in China, effective February 2023, reclassified choline from an optional ingredient to a required component in infant and follow-on formula. This regulatory shift has elevated choline's visibility and consumer awareness. In the US, the FDA has specific requirements for children's supplement labeling, and the AAP recommends supplementation only for specific nutrients where deficiency risk is documented (vitamin D, iron for certain populations).

F. Formulation Considerations: Sugar reduction in gummies without compromising palatability or shelf stability is a significant formulation challenge. Natural sweeteners and sugar alcohols require careful evaluation for children's tolerance. Choline's taste profile (often described as fishy or bitter) requires masking in children's formulations.

 

A. Featured Ingredients: Beta-glucan, vitamin D, zinc, medicinal mushroom extracts (reishi, shiitake, turkey tail)

B. Market Condition: The immune support category has undergone a permanent shift from seasonal (cold and flu season) to year-round positioning. Consumers now view immune health as a foundational component of daily wellness, not a reactive measure. This shift has expanded the addressable market substantially.

C. Target Users: All age groups, with particularly strong engagement from parents of school-aged children, older adults, and individuals with occupational exposure risks (healthcare workers, teachers, and frequent travelers).

D. Formulation and Delivery: Capsules and tablets remain standard for beta-glucan and mushroom extracts. Powders for immune support are gaining traction, particularly when combined with vitamin C and zinc. Gummies offer a convenient format for children's immune products.

E. Regulatory Environment: In the EU, authorized immune claims include "vitamin D contributes to the normal function of the immune system," "zinc contributes to the normal function of the immune system," and similar claims for vitamin C, selenium, and copper. Beta-glucan claims typically require Article 13.5 submissions with proprietary scientific evidence, though some Article 13.1 claims exist for specific beta-glucan sources. In the US, structure/function claims for immune support are permitted with the standard disclaimer.

F. Formulation Considerations: Beta-glucan from yeast (Saccharomyces cerevisiae) and beta-glucan from oats have different molecular structures and biological activities. Yeast β glucan, with its beta-1,3/1,6 linkage, has the most robust research support for immune receptor binding. Mushroom extracts require careful standardization; beta-glucan and alpha-glucan content are key quality markers.

 

A cross-cutting theme across all ten categories is the transformation of delivery formats. Traditional tablets and capsules have experienced consistent declines since 2020, while gummies, powders, and liquids have captured an ever-growing share of the market.

Gummies have more than doubled in market value since 2020, transforming from a niche children's format to a mainstream delivery system for adult supplements. Their appeal lies in the enjoyable consumption experience, elimination of swallowing difficulties, and the transformation of a clinical-feeling routine into something consumers look forward to.

Powders represent one of the fastest-growing segments, driven by several factors: customizable dosing, the ability to combine multiple ingredients at meaningful levels, mixability with beverages, and potentially superior absorption profiles. Stick packs offer single-serve convenience and are particularly popular for travel and on-the-go use.

Liquid supplements have experienced a resurgence, appealing to consumers seeking faster absorption and those who struggle with pills. This format is particularly relevant for older adults and children.

The formulation considerations are significant. Agglomeration and instantizing technologies are critical for powder products that must disperse instantly and consistently fill stick packs. Microencapsulation addresses taste masking and stability challenges. Gummy formulation requires expertise in pectin or gelatin systems, sugar reduction, and active ingredient stability throughout shelf life.

 

Inhealth Nature partners with brands to navigate this complexity. From ingredient sourcing and formulation development to regulatory strategy and finished product manufacturing, we provide the infrastructure that turns market insight into market-ready products. Whether you are developing a next-generation sleep formulation, exploring postbiotic applications, or building a longevity platform, our team offers the technical depth and regulatory fluency to accelerate your path to market.

We invite brands, formulators, and manufacturers to explore partnership opportunities with Inhealth Nature. For inquiries regarding contract manufacturing, ingredient sourcing, or formulation consultation, please contact us at info@inhealthnature.com. Together, we can bring the next generation of evidence-based supplements to consumers worldwide.

 

References

[1] Nutraceuticals World. "Vitaquest Announces Trend Predictions for 2027." October 2026.

[2] FDA. "How to Submit Notifications for a New Dietary Ingredient."

[3] Court of Justice of the European Union. Judgment in Case C-386/23, Novel Nutriology GmbH v Verband Sozialer Wettbewerb eV. 30 April 2025. Press Release No 57/25.

[4] European Parliament and Council of the European Union. Regulation (EC) No 1924/2006 on nutrition and health claims made on foods. 20 December 2006.

[5] FDA. "FDA 101: Dietary Supplements." March 2025.

[6] New Hope Network. "Analyst's Take: Delivery innovation is transforming supplement growth." July 2025.

[7] Research and Markets. "Dietary Supplements – Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)."

[8] NutraIngredients. "What can brands say about mind health supplements under EU Law?" October 2025.

[9] Traple Konarski Podrecki and Partners. "Prohibition on the use of health claims for botanicals in advertisements." June 2025.

[10] FDA. "New Dietary Ingredients in Dietary Supplements – Background for Industry."